Literature DB >> 21775738

Immune thrombocytopenic purpura in a patient with multiple sclerosis treated with natalizumab.

M Stosic1, P De Jesus, J McCarthy, G Hutton, V Rivera.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21775738     DOI： 10.1212/WNL.0b013e318227b23f

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  2 in total

1.  Interferon-β therapy and risk of thrombocytopenia in multiple sclerosis patients.

Authors:  Tatiana Koudriavtseva; Domenico Plantone; Rosaria Renna; Chiara Mandoj; Diana Giannarelli; Caterina Mainero
Journal:  Neurol Sci       Date:  2015-07-26       Impact factor: 3.307

2.  Drug-induced thrombocytopenia secondary to natalizumab treatment.

Authors:  David Cachia; Saef Izzy; Idanis Berriosmorales; Carolina Ionete
Journal:  BMJ Case Rep       Date:  2014-05-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.